McKinley Carter Wealth Services’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,426
Closed -$127K 438
2018
Q1
$127K Sell
1,426
-1,718
-55% -$165K 0.04% 198
2017
Q4
$328K Sell
3,144
-460
-13% -$51.9K 0.11% 119
2017
Q3
$526K Hold
3,604
0.2% 85
2017
Q2
$468K Buy
3,604
+570
+19% +$69.8K 0.21% 76
2017
Q1
$378K Buy
3,034
+280
+10% +$33.5K 0.18% 85
2016
Q4
$319K Buy
2,754
+670
+32% +$74.6K 0.16% 89
2016
Q3
$218K Hold
2,084
0.11% 114
2016
Q2
$206K Buy
2,084
+57
+3% +$5.9K 0.11% 120
2016
Q1
$203K Buy
+2,027
New +$209K 0.11% 123

Other funds holding CELG

McKinley Carter Wealth Services's CELG Position: Q2 2018 in Review

McKinley Carter Wealth Services sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 1,426 shares — an estimated $127K sold.

McKinley Carter Wealth Services first reported a position in CELG in Q1 2016 and held it in 9 quarters. The position peaked at $526K in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • McKinley Carter Wealth Services reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • McKinley Carter Wealth Services sold 1,426 Celgene Corp shares in Q2 2018, an estimated $127K.
  • McKinley Carter Wealth Services first reported a position in Celgene Corp in Q1 2016 and held it in 9 quarters.
  • McKinley Carter Wealth Services's Celgene Corp position peaked at $526K in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on McKinley Carter Wealth Services's 13F filing for Q2 2018, filed 7 Dec 2018.